CN115043757A - Method for continuously preparing benzamidine hydrochloride - Google Patents

Method for continuously preparing benzamidine hydrochloride Download PDF

Info

Publication number
CN115043757A
CN115043757A CN202210891543.1A CN202210891543A CN115043757A CN 115043757 A CN115043757 A CN 115043757A CN 202210891543 A CN202210891543 A CN 202210891543A CN 115043757 A CN115043757 A CN 115043757A
Authority
CN
China
Prior art keywords
catalyst
benzamidine hydrochloride
compound
continuous process
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202210891543.1A
Other languages
Chinese (zh)
Other versions
CN115043757B (en
Inventor
陈剑
余长泉
田太谦
康俊
郭士超
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Huaguan Biotechnology Co ltd
Original Assignee
Nanjing Huaguan Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Huaguan Biotechnology Co ltd filed Critical Nanjing Huaguan Biotechnology Co ltd
Priority to CN202210891543.1A priority Critical patent/CN115043757B/en
Publication of CN115043757A publication Critical patent/CN115043757A/en
Application granted granted Critical
Publication of CN115043757B publication Critical patent/CN115043757B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/42Platinum
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J35/00Catalysts, in general, characterised by their form or physical properties
    • B01J35/40Catalysts, in general, characterised by their form or physical properties characterised by dimensions, e.g. grain size
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J35/00Catalysts, in general, characterised by their form or physical properties
    • B01J35/50Catalysts, in general, characterised by their form or physical properties characterised by their shape or configuration
    • B01J35/51Spheres
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J35/00Catalysts, in general, characterised by their form or physical properties
    • B01J35/60Catalysts, in general, characterised by their form or physical properties characterised by their surface properties or porosity
    • B01J35/61Surface area
    • B01J35/615100-500 m2/g
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/584Recycling of catalysts

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The invention relates to the technical field of drug intermediate synthesis, in particular to a method for continuously preparing benzamidine hydrochloride; the method comprises the following steps:

Description

Method for continuously preparing benzamidine hydrochloride
Technical Field
The invention relates to the technical field of synthesis of drug intermediates, in particular to a method for continuously preparing benzamidine hydrochloride.
Background
Benzamidine hydrochloride is a key intermediate of vardenafil analogues, N-hydroxy benzamidine is basically used for hydrogenation reduction in an autoclave in the prior art, the safety risk is high, and a catalyst is palladium carbon and is expensive.
Disclosure of Invention
The purpose of the invention is: overcomes the technical defects of high catalyst price and high reaction safety coefficient in the prior art, and provides a method for continuously preparing benzamidine hydrochloride.
In order to achieve the purpose, the technical scheme adopted by the invention is as follows:
a process for the continuous preparation of benzamidine hydrochloride, said intermediate being 2-ethoxy (or 2-propoxybenzamidine hydrochloride, comprising the steps of:
Figure BDA0003767745010000011
wherein: r is methoxy, ethoxy or propoxy;
firstly, pumping the solution of the compound 1 and hydrogen into a fixed bed reactor filled with a catalyst respectively, and then reacting at a certain temperature and a certain pressure to generate a compound 2.
Further, the reaction temperature of the compound 1 solution in the fixed bed is 50-150 ℃, and the retention time of the reaction liquid in the fixed bed is less than 15 min.
Further, the solvent used in the compound 1 solution is one or more of methanol, ethanol, isopropanol and acetic acid.
Further, the catalyst is a metal catalyst of immobilized platinum, and the carrier of the immobilized catalyst is SiO 2 、Al 2 O 3 Or one or more of activated carbon.
Further, the catalyst is microspheres with the diameter of 0.5-4 mm.
Further, the catalyst is microspheres with the diameter of 1-2 mm.
Further, the preparation method of the catalyst comprises the following steps:
s1 adding 15g chloroplatinic acid into 800g 5% NaOH aqueous solution and 50g spherical activated carbon (diameter 1-2mm), soaking for 3-4h, filtering, drying, and drying by air blast at 110 ℃ to constant weight;
s2, after drying by blowing, transferring the mixture to a tubular furnace, under the protection of nitrogen, heating the mixture for 1 hour to 350 ℃, then switching to hydrogen, reducing the mixture for 2 hours at the temperature of 350 ℃, and then switching to nitrogen to slowly cool the mixture to room temperature for later use;
s3 is soaked in 0.5 percent acetic acid aqueous solution for 24 hours, and then is filtered, washed twice by deionized water, and is dried by blowing at the temperature of 110 ℃ for 24 hours in 100 ℃ to obtain 45-50.00g of Pt/C immobilized catalyst (spherical with the diameter of 1-2 mm).
Further, the mass concentration of the compound 1 solution is 5-15%, the reaction temperature is 50-150 ℃, the reaction pressure is 0.5-30 Mpa, and the reaction residence time is less than 15 min.
Advantageous effects
The platinum catalyst (main producers: Shaanxi Rui Ke Li) available in the market at present has the defects of irregular active carbon as a carrier, uneven specific surface area, low mechanical strength, low activity and short service life, and improves the preparation process of the Pt carbon supported catalyst.
The method is a continuous, safe and reliable synthesis method, uses cheap catalyst, and is an effective method suitable for industrial production. The reaction solution does not need special treatment, and the purity of the product can reach more than 99 percent. Is an effective method with simple and safe operation, low cost and easy industrialized production.
Detailed Description
The invention is further illustrated by the following examples, which are not intended to limit the scope of the invention. The experimental methods without specifying specific conditions in the following examples were selected according to the conventional methods and conditions, or according to the commercial instructions. If the temperature is not particularly emphasized, the reaction is usually carried out at room temperature, and the room temperature in the present invention is 10 to 30 ℃.
Example 1: preparation of the catalyst
(1)15g of chloroplatinic acid, 800g of 5 percent NaOH aqueous solution and 50g of spherical activated carbon (1-2mm) are added, soaked for 4 hours, filtered and dried, and blown and dried at the temperature of 100 ℃ and 110 ℃ to constant weight.
(3) After blast drying, transferring to a tubular furnace, heating to 350 ℃ for 1h under the protection of nitrogen, then switching to hydrogen, reducing at 350 ℃ for 2h, and then switching to nitrogen to slowly cool to room temperature for later use.
(4) Soaking the catalyst in 0.5% acetic acid water solution for 24h, filtering, washing with deionized water twice, and drying by blowing at the temperature of 110 ℃ for 24h to obtain 48.00g of Pt/C immobilized catalyst.
Catalyst producer Specific surface area (m2/g) Mechanical Strength (N/grain) Percent conversion in the reaction% Life span
Xian Kaili 100-200 20-30 90.0 6 days
Self-made 280-360 50-80 97.5 10 days
Example 2: intermittent mode
Adding 2-propoxy-N-hydroxybenzamidine (100.0g), acetic acid (500mL) and 10% palladium carbon (10g) into an autoclave, replacing 3 times with nitrogen and 3 times with hydrogen, heating to 60 ℃ for reaction for 4-8h, cooling to room temperature after the reaction is completed, filtering out the palladium carbon, adding concentrated hydrochloric acid (80g), concentrating, adding toluene (100mL), concentrating to dryness, adding 500mL methyl tert-butyl ether for crystallization, performing suction filtration and drying to obtain 104.5g of 2-propoxybenzamidine hydrochloride, LC-MS (M +1):179.20, wherein the HPLC purity is 99.2%, and the yield is as follows: 94.5 percent
Example 3: continuous mode
4.5g of self-made Pt/C immobilized catalyst is added into a European Shengshi full-automatic hydrogenation instrument (a packed column is 5.6mL), after nitrogen replacement, the hydrogen backpressure is switched to 2.5Mpa, hydrogen starts to be introduced, 35mL/min is carried out, a feeding pump is started at the temperature of 80 ℃, a raw material liquid containing (100g of 2-propoxy-N-hydroxybenzamidine, 500g of ethanol and 100g of acetic acid) is conveyed into a reactor, the flow is 0.35mL/min, sampling is carried out after the system is stable, and the reaction is qualified. Concentrated hydrochloric acid (80g) was added to the reaction mixture, concentrated to dryness, and 500mL of methyl t-butyl ether was added to the mixture to conduct crystallization, followed by suction filtration and drying to obtain 106.0g of 2-propoxybenzamidine hydrochloride, LC-MS (M +1):179.20,1HNMR (δ ppm, DMSO-d6, 400MHz)9.42(s, 2H),9.21(s, 2H),7.58 to 7.62(t, 1H, J ═ 4Hz),7.52 to 7.54(d,1H, J ═ 8Hz),7.22 to 7.24(d,1H, J ═ 8Hz),7.08 to 7.12(t, 1H, J ═ 4Hz),4.02 to 4.06(t,2H, J ═ 8Hz), 1.72 to 1.80(M, 2H),0.97 to 1.01(t,3H, J ═ 4Hz), HPLC 99.3%, purity: 95.9 percent.
Example 4: continuous mode
40.00g of self-made Pt/C supported catalyst is added into a 55mL filling column (with a jacket), the back pressure of nitrogen is 2.5Mpa, hydrogen is switched in, and hydrogen is introduced for replacement for 10min, and the flow rate is 250 mL/min.
Setting the temperature of jacket circulating oil at 80 ℃, starting a feeding pump after the temperature is constant, conveying a raw material liquid containing (500g of 2-propoxy-N-hydroxybenzamidine, 2500g of ethanol and 500g of acetic acid) into a reactor, wherein the flow rate is 3.5mL/min, sampling is started after the system is stable, and the reaction is qualified. Concentrated hydrochloric acid (400g) is added into the reaction solution, concentrated to dryness, 2.5L methyl tert-butyl ether is added into the reaction solution for crystallization, and 525.0g of 2-propoxybenzamidine hydrochloride is obtained after suction filtration and drying, the HPLC purity is 98.9 percent, and the yield is as follows: 94.9 percent.
The above-mentioned embodiments only express several embodiments of the present invention, and the description thereof is more specific and detailed, but not construed as limiting the scope of the invention. It should be noted that, for a person skilled in the art, several variations and modifications can be made without departing from the inventive concept, which falls within the scope of the present invention. Therefore, the protection scope of the present invention should be subject to the appended claims.

Claims (8)

1. A process for the continuous preparation of benzamidine hydrochloride, the intermediate being 2-ethoxy (or 2-propoxy benzamidine hydrochloride, characterized in that it comprises the steps of:
Figure FDA0003767734000000011
wherein: r is methoxy, ethoxy or propoxy;
firstly, pumping the solution of the compound 1 and hydrogen into a fixed bed reactor filled with a catalyst respectively, and then reacting at a certain temperature and a certain pressure to generate a compound 2.
2. The continuous process for preparing benzamidine hydrochloride according to claim 1, characterized in that: the reaction temperature of the compound 1 solution in the fixed bed is 50-150 ℃, and the residence time of the reaction liquid in the fixed bed is less than 15 min.
3. The continuous process for preparing benzamidine hydrochloride according to claim 1, characterized in that: the solvent used by the compound 1 solution is one or more of methanol, ethanol, isopropanol and acetic acid.
4. The continuous process for preparing benzamidine hydrochloride according to claim 1A method of salt, characterized by: the catalyst is a metal catalyst of immobilized platinum, and the carrier of the immobilized catalyst is SiO 2 、Al 2 O 3 Or one or more of activated carbon.
5. The continuous process for preparing benzamidine hydrochloride according to claim 1, characterized in that: the catalyst is a microsphere with the diameter of 0.5-4 mm.
6. The continuous process for preparing benzamidine hydrochloride according to claim 1, characterized in that: the catalyst is microspheres with the diameter of 1-2 mm.
7. The continuous process for the preparation of benzamidine hydrochloride according to any one of claims 4-6, characterized in that: the preparation method of the catalyst comprises the following steps:
s1 adding 15g chloroplatinic acid into 800g 5% NaOH aqueous solution and 50g spherical activated carbon (diameter 1-2mm), soaking for 3-4h, filtering, drying, and drying by air blast at 110 ℃ to constant weight;
s2, after drying by blowing, transferring the mixture to a tubular furnace, under the protection of nitrogen, heating the mixture for 1 hour to 350 ℃, then switching to hydrogen, reducing the mixture for 2 hours at the temperature of 350 ℃, and then switching to nitrogen to slowly cool the mixture to room temperature for later use;
s3 is soaked in 0.5 percent acetic acid aqueous solution for 24 hours, and then is filtered, washed twice by deionized water, and is dried by blowing at the temperature of 110 ℃ for 24 hours in 100 ℃ to obtain 45-50.00g of Pt/C immobilized catalyst (spherical with the diameter of 1-2 mm).
8. The continuous process for preparing benzamidine hydrochloride according to claim 1, characterized in that: the mass concentration of the compound 1 solution is 5-15%, the reaction temperature is 50-150 ℃, the reaction pressure is 0.5-30 Mpa, and the reaction retention time is less than 15 min.
CN202210891543.1A 2022-07-27 2022-07-27 Method for continuously preparing benzamidine hydrochloride Active CN115043757B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210891543.1A CN115043757B (en) 2022-07-27 2022-07-27 Method for continuously preparing benzamidine hydrochloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210891543.1A CN115043757B (en) 2022-07-27 2022-07-27 Method for continuously preparing benzamidine hydrochloride

Publications (2)

Publication Number Publication Date
CN115043757A true CN115043757A (en) 2022-09-13
CN115043757B CN115043757B (en) 2023-08-08

Family

ID=83168071

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210891543.1A Active CN115043757B (en) 2022-07-27 2022-07-27 Method for continuously preparing benzamidine hydrochloride

Country Status (1)

Country Link
CN (1) CN115043757B (en)

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1481386A (en) * 2000-12-18 2004-03-10 Method for producing sulfonamide-substituted imidazotriazinones
CN1489575A (en) * 2001-01-29 2004-04-14 ������������ʽ���� Benzamidine derivatives and process for producing same
CN1830955A (en) * 2005-11-07 2006-09-13 山东师范大学 Method for synthesizing O-ethoxy phenyl formamidine acetate
CN1846852A (en) * 2005-04-15 2006-10-18 北京有色金属研究总院 Prepn process of carbon supported platinum catalyst
CN1894235A (en) * 2003-12-19 2007-01-10 弗·哈夫曼-拉罗切有限公司 N-(4-carbamimidoyl-benzyl) -2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia
CN101029023A (en) * 2007-02-02 2007-09-05 广东东阳光药业有限公司 Production of picolyl ether and its salt
CN101502797A (en) * 2008-12-30 2009-08-12 西安凯立化工有限公司 Platinum-based selective hydrogenation catalyst as well as preparation method and use thereof
CN103349983A (en) * 2013-07-27 2013-10-16 西安凯立化工有限公司 Catalyst for preparing halogenated aniline through catalytic hydrogenation of halogenated nitrobenzene and application thereof
CN104549235A (en) * 2014-12-19 2015-04-29 上海交通大学 Preparation method of carbon supported nano platinum catalyst
CN106252677A (en) * 2016-08-03 2016-12-21 陕西瑞科新材料股份有限公司 A kind of preparation method of charcoal platinum catalyst
CN106565539A (en) * 2016-11-05 2017-04-19 王密治 Method for synthesizing benzamidine derivative
CN110878032A (en) * 2019-10-31 2020-03-13 苏州诚和医药化学有限公司 Synthesis method of N-benzylacetamidine hydrochloride
CN112934218A (en) * 2019-12-10 2021-06-11 中国科学院大连化学物理研究所 Platinum-carbon catalyst, preparation and application thereof

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1481386A (en) * 2000-12-18 2004-03-10 Method for producing sulfonamide-substituted imidazotriazinones
CN1489575A (en) * 2001-01-29 2004-04-14 ������������ʽ���� Benzamidine derivatives and process for producing same
CN1894235A (en) * 2003-12-19 2007-01-10 弗·哈夫曼-拉罗切有限公司 N-(4-carbamimidoyl-benzyl) -2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia
CN1846852A (en) * 2005-04-15 2006-10-18 北京有色金属研究总院 Prepn process of carbon supported platinum catalyst
CN1830955A (en) * 2005-11-07 2006-09-13 山东师范大学 Method for synthesizing O-ethoxy phenyl formamidine acetate
CN101029023A (en) * 2007-02-02 2007-09-05 广东东阳光药业有限公司 Production of picolyl ether and its salt
CN101502797A (en) * 2008-12-30 2009-08-12 西安凯立化工有限公司 Platinum-based selective hydrogenation catalyst as well as preparation method and use thereof
CN103349983A (en) * 2013-07-27 2013-10-16 西安凯立化工有限公司 Catalyst for preparing halogenated aniline through catalytic hydrogenation of halogenated nitrobenzene and application thereof
CN104549235A (en) * 2014-12-19 2015-04-29 上海交通大学 Preparation method of carbon supported nano platinum catalyst
CN106252677A (en) * 2016-08-03 2016-12-21 陕西瑞科新材料股份有限公司 A kind of preparation method of charcoal platinum catalyst
CN106565539A (en) * 2016-11-05 2017-04-19 王密治 Method for synthesizing benzamidine derivative
CN110878032A (en) * 2019-10-31 2020-03-13 苏州诚和医药化学有限公司 Synthesis method of N-benzylacetamidine hydrochloride
CN112934218A (en) * 2019-12-10 2021-06-11 中国科学院大连化学物理研究所 Platinum-carbon catalyst, preparation and application thereof

Also Published As

Publication number Publication date
CN115043757B (en) 2023-08-08

Similar Documents

Publication Publication Date Title
WO2016095136A1 (en) Method for purifying 1,5-pentanediamine and 1,5-pentanediamine
JP7050066B2 (en) Methods and systems for producing glycolic acid and / or glycolates
CN113731465A (en) Pd/N-CNTs catalyst, and preparation method and application thereof
CN109529880B (en) Catalyst regeneration method
KR101105460B1 (en) Method for preparing sugar alcohols using ruthenium zirconia catalyst
CN115043757A (en) Method for continuously preparing benzamidine hydrochloride
CN108341427B (en) Method for synthesizing stannous chloride
JPH04225836A (en) Worganic body carried catalyst for producing ethylidenediacetate, its manufacture and manufacture of ethylidenediacetate using the same
EP2524909B1 (en) Preparation method of 4-aminomethylbenzoic acid
JPS6041647B2 (en) Method for producing 1,1,1,3,3,3-hexafluoropropan-2-ol
CN103769087A (en) Supported palladium catalyst for production of hydrogen peroxide through anthraquinone hydrogenation method, and preparation method thereof
KR100688765B1 (en) Method for preparing cis-cyclohexanediol with a high yield and a high purity from benzendiol
KR20090034772A (en) Catalyst
CN112724027B (en) Preparation method of isoproterenol hydrochloride
JP2573687B2 (en) Method for producing isopropyl alcohol
US4120819A (en) Method for platinum or palladium catalyst reactivation
EP2134470B1 (en) Supported palladium catalyst and process for producing it
CN114644636B (en) Method for preparing tofacitinib key intermediate
JPH06306020A (en) Production of 4-aminodiphenylamine
CN112851508A (en) Preparation method of Barosavir intermediate
CN114605301B (en) Method for preparing Pa Luo Weide intermediate
JP4698421B2 (en) Process for producing 2,3,6,7,10,11-hexahydroxytriphenylene
KR100710559B1 (en) Method for the effective preparation of 1-cyclohexyl-1-ethanol
CN115991686B (en) Method for preparing 2, 5-furandicarboxylic acid
CN110841636B (en) Catalyst for preparing 5-amino isophthalic acid and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant